Search
Morimatsu has successfully delivered integrated upstream and downstream projects to produce insulin, monoclonal antibodies, vaccines, recombinant albumin, recombinant factor, ADC (antibody-drug conjugates), polypeptides, etc. to many well-known biopharmaceutical manufacturers. Our design ensures minimum product loss, optimized CIP and SIP functions as well as ease of operation and maintenance. Our risk-based process control eliminates concerns, ensuring that the final operation works exactly in line with expectations.
Bioreactor/fermentation system、Media preparation system、Harvesting system、Purification system、Sterile formation preparation system、Buffer preparation and storage system、Inactivation and CIP workstation system、Single-use magnetic mixing system、Single-use storage system、Inline Conditioning System.
